ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000040 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
3,816
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 1,908 | $0.00 | $0.00 | 61,710 | Direct | โ | View Details | |
EVP, Chief Financial Officer | Restricted Stock Units | Derivative | Feb 27, 2026 | Exercise/Conversion | 1,908 | $0.00 | $0.00 | 0 | Direct | โ | View Details |